Bayer CropScience profit jumps 21% on flat sales
Revenue grew just 3.7% in FY26, but net profit surged 21.3% to ₹689 crore. The board recommended a ₹60 per share dividend.
What's new
- FY26 revenue rose 3.7% to ₹5,675 crore.
- Net profit grew 21.3% to ₹689 crore, outpacing sales growth.
- Board recommends final dividend of ₹60 per share.
Why this matters
Profit grew almost six times faster than revenue. The results are routine, but the spread between top-line and bottom-line growth is wide enough to invite questions about what changed in the cost structure. The ₹60 dividend is a straightforward cash return.
What we're watching
- Whether cost savings are permanent or driven by one-time items.
- Management commentary on input costs for FY27.
- Capex plans for new molecules or formulation capacity.
The full read
Bayer CropScience closed FY26 with revenue of ₹5,675 crore, up 3.7%. The bottom line grew far faster: net profit of ₹689 crore marks a 21.3% jump. That spread is wide. A company growing sales at under 4% and profits at over 20% is either cutting costs hard, repricing products, or both. The filing does not say which. The board also recommended a final dividend of ₹60 per share. These are standard annual results. They were anticipated, and they contained no surprises or guidance changes to force analyst model revisions. The open question is whether the cost discipline behind the profit surge is structural or a one-off.
Questions answered
- How much did Bayer CropScience earn in FY26?
- Revenue was ₹5,675 crore, up 3.7% year-on-year. Net profit was ₹689 crore, a 21.3% increase.
- Why did profit grow faster than revenue?
- The filing doesn't say. A 3.7% revenue rise feeding a 21.3% profit jump means costs fell faster than sales grew. The specific drivers are not in this announcement.
- What is the final dividend?
- The board recommended ₹60 per share.
- Is this a surprise?
- No. The rationale calls this a routine annual disclosure with widespread market anticipation and no material surprises or guidance changes.